We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Conducts Fewer GMP, More GCP and Pharmacovigilance Inspections
EMA Conducts Fewer GMP, More GCP and Pharmacovigilance Inspections
The EMA noted a steep decrease in GMP inspections in its annual report for 2017, as well as a hike in inspections for good clinical practices and nearly double the amount of pharmacovigilance inspections than the previous year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor